Javascript must be enabled to continue!
P4675The utility of additional balloon pulmonary angioplasty for residual hypoxemia in normohemodynamic chronic thromboembolic pulmonary hypertension patients after invasive treatments
View through CrossRef
Abstract
Background
Balloon pulmonary angioplasty (BPA) improves hemodynamics, symptoms and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are ineligible for pulmonary endarterectomy (PEA). However, certain patients still have hypoxemia after BPA or PEA despite normalization of hemodynamics. In CTEPH, hypoxemia is related increased dead space ventilation caused by vascular obstruction.
Purpose
This study was aimed to clarify whether additional BPA can improve hypoxemia of CTEPH patients after normalization of hemodynamics.
Methods
A total of 335 patients who underwent initial series of BPA in our institute were followed up. Sixty-four patients with mean pulmonary artery pressure (mPAP) <30mmHg and percutaneous oxygen saturation (SpO2) <95% without oxygen inhalation at more than 6 months after the initial series of BPA and of patients who could reevaluate hemodynamics and oxygenation after additional BPA were enrolled. These patients were divided into two groups with or without additional BPA procedures. Change of hemodynamics and SpO2 were retrospectively investigated.
Results
Thirty-three of 64 patients underwent additional BPA procedures. Patients' age was older in BPA group than those in non-BPA group (71.3±10.4 vs. 66.5±9.4 years old, p=0.02). mPAP and pulmonary vascular resistance (PVR) was significantly higher in BPA group (mPAP: 23.9±3.2 vs. 20.7±3.8 mmHg, p=0.001, PVR: 4.2±1.2 vs. 3.5±1.4 wood unit, p=0.03, respectively). Among the 1.8±1.4 BPA procedures per person, total 6.6±3.8 segmental pulmonary arteries per person were treated. While no obvious improvements were observed in non-BPA group, PVR and SpO2 in BPA group were significantly improved (4.2±1.2 to 3.7±1.3 wood unit, p=0.002, 90.7±3.1% to 94.1±3.6%, p<0.001, respectively). In the multivariate logistic regression analysis, additional BPA procedures were associated with further improvement of SpO2 (hazard ratio, 3.7; 95% confidence interval, 1.2–11.5; P=0.02).
Conclusions
Additional BPA procedure was associated with improvement of hypoxemia in CTEPH patients after normalization of hemodynamics. Treating as many lesions as possible in BPA might relieve the patients' residual dyspnea.
Oxford University Press (OUP)
Title: P4675The utility of additional balloon pulmonary angioplasty for residual hypoxemia in normohemodynamic chronic thromboembolic pulmonary hypertension patients after invasive treatments
Description:
Abstract
Background
Balloon pulmonary angioplasty (BPA) improves hemodynamics, symptoms and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are ineligible for pulmonary endarterectomy (PEA).
However, certain patients still have hypoxemia after BPA or PEA despite normalization of hemodynamics.
In CTEPH, hypoxemia is related increased dead space ventilation caused by vascular obstruction.
Purpose
This study was aimed to clarify whether additional BPA can improve hypoxemia of CTEPH patients after normalization of hemodynamics.
Methods
A total of 335 patients who underwent initial series of BPA in our institute were followed up.
Sixty-four patients with mean pulmonary artery pressure (mPAP) <30mmHg and percutaneous oxygen saturation (SpO2) <95% without oxygen inhalation at more than 6 months after the initial series of BPA and of patients who could reevaluate hemodynamics and oxygenation after additional BPA were enrolled.
These patients were divided into two groups with or without additional BPA procedures.
Change of hemodynamics and SpO2 were retrospectively investigated.
Results
Thirty-three of 64 patients underwent additional BPA procedures.
Patients' age was older in BPA group than those in non-BPA group (71.
3±10.
4 vs.
66.
5±9.
4 years old, p=0.
02).
mPAP and pulmonary vascular resistance (PVR) was significantly higher in BPA group (mPAP: 23.
9±3.
2 vs.
20.
7±3.
8 mmHg, p=0.
001, PVR: 4.
2±1.
2 vs.
3.
5±1.
4 wood unit, p=0.
03, respectively).
Among the 1.
8±1.
4 BPA procedures per person, total 6.
6±3.
8 segmental pulmonary arteries per person were treated.
While no obvious improvements were observed in non-BPA group, PVR and SpO2 in BPA group were significantly improved (4.
2±1.
2 to 3.
7±1.
3 wood unit, p=0.
002, 90.
7±3.
1% to 94.
1±3.
6%, p<0.
001, respectively).
In the multivariate logistic regression analysis, additional BPA procedures were associated with further improvement of SpO2 (hazard ratio, 3.
7; 95% confidence interval, 1.
2–11.
5; P=0.
02).
Conclusions
Additional BPA procedure was associated with improvement of hypoxemia in CTEPH patients after normalization of hemodynamics.
Treating as many lesions as possible in BPA might relieve the patients' residual dyspnea.
Related Results
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Background: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are chronic diseases with a severe symptom burden. Common symptoms are dyspnoea at lig...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Risk factors for intraprocedural hypoxemia in patients with acute cerebral ischemia treated with vascular intervention and its impact on prognosis: A retrospective cohort study
Risk factors for intraprocedural hypoxemia in patients with acute cerebral ischemia treated with vascular intervention and its impact on prognosis: A retrospective cohort study
Abstract:
BACKGROUND:
Acute cerebral infarction (ACI) is one of the most common ischemic cerebrovascular diseases in neurology, with high morbidi...
P4678The hemodynamic improvement with balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension depends on the lesion location
P4678The hemodynamic improvement with balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension depends on the lesion location
Abstract
Background
Pulmonary endarterectomy (PEA) is a treatment of choice for patients with chronic thromboembolic pulmonary h...
Haemodynamic and Clinical Impacts of Switching Phosphodiesterase-5 Inhibitors to Riociguat in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) after Balloon Pulmonary Angioplasty (BPA) – A Prospective Cohort Study
Haemodynamic and Clinical Impacts of Switching Phosphodiesterase-5 Inhibitors to Riociguat in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) after Balloon Pulmonary Angioplasty (BPA) – A Prospective Cohort Study
Abstract
Background
For patients with chronic thromboembolic pulmonary hypertension (CTEPH), balloon pulmonary angioplasty (BPA) has been associated with superior reduction...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
P885 Pulmonary artery stent implantation in an adult with chronic thromboembolic pulmonary stenosis
P885 Pulmonary artery stent implantation in an adult with chronic thromboembolic pulmonary stenosis
Abstract
Introduction
Pulmonary artery stenosis presenting in adults is rare. Chronic thromboembolic pulmonary hypertension (CTE...


